ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.
July 16, 2021
Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures
July 16, 2021 — Mayo Clinic recently became the first to use a next-generation 4-D intracardiac echo (ICE) imaging…
Read More
The Clear AI software can help with identification coronary plaque features in CT scans that may cause heart attacks. Cleerly Coronary’s noninvasive, AI-driven approach supports the understanding of plaques using FDA-cleared technologies.
July 16, 2021
Canon Medical Partners with Cleerly to Tackle Heart Disease, the Leading Cause of Death
July 16, 2021 — Canon Medical Systems USA is joining forces with Cleerly in a strategic partnership to support simple…
Read More
New trial results from the international RAPID Trial show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of severe disease and death. How to anticoagulate COVID patients. How to prevent thrombus in COVID patients.
July 15, 2021
Study Supports Early Anticoagulant Treatment to Reduce Death in Moderately Ill COVID-19 Patients
July 15, 2021 — COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly…
Read More
An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.
July 15, 2021
HeartFlow Becomes Publicly Traded Company in Merger With Longview Acquisition Corp.
July 15, 2021 — HeartFlow, which has commercialized noninvasive computed tomography derived fractional flow reserve (…
Read More
Diluting of a blood sample for real-time deformability cytometry testing. Researchers at the Max-Planck-Zentrum für Physik und Medizin in Erlangen. Germany, were able to show for the first time COVID-19 significantly changes the size and stiffness of red and white blood cells, sometimes over months. From the study How a COVID-19 Infection Changes Blood Cells in the Long Run. Reasons for long COVID.
July 15, 2021
COVID-19 Changes Properties Blood Cells 
July 15, 2021 — Using real-time deformability cytometry, researchers at the Max-Planck-Zentrum für Physik und Medizin…
Read More
Leveraging Vivasure Medical’s PerQseal vascular closure device technology, PerQseal Blue consists of an intravascular patch designed to seal the vessel from the inside, returning the vein to its natural state after it dissolves over time, so no foreign bodies are left behind.
July 15, 2021
Vivasure Medical is Developing a Sutureless Venous Closure Device for Transcatheter Valve Procedures
July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully…
Read More
The inherent spectral capabilities of Mayo Clinic's new third-generation photon-counting CT research scanner allows clear visualization of the intact portions of the coronary artery lumen (arrowhead) by reducing the bright signal from the dense coronary calcifications (arrows). Spectral CT is able to bin photos on different energies that can be used to enhance or subtract chemical elements based on their spectral signature, such as calcium shown here, and iodine.
July 14, 2021
Mayo Clinic Begins Use of New Photon-counting CT Detector
July 14, 2021 — Performing the first cardiac scan on their new photon-counting detector computed tomography (CT)…
Read More
Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.
July 14, 2021
Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care
June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of…
Read More
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
July 14, 2021
FDA Clears SafeCross Transseptal RF Puncture and Steerable Balloon Introducer System
July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the…
Read More
An example of a strain echo from the study showing reduced peak longitudinal/reservoir left atrial strain in a COVID-19 patient who developed atrial fibrillation during admission. Average left atrial strain here is 20% (normal should be above 38%).
July 14, 2021
Speckle Tracking Strain Echo May Predict Heart Complications From COVID-19
July 13, 2021 — Researchers at Johns Hopkins Medicine have shown that speckle-tracking strain echocardiograms may…
Read More
Humana’s new draft Fusion policy outlines coverage determinations for myocardial assessment and the use of PET/CT and SPECT/CT for certain neurologic indications. ASNC has submitted additional feedback on the draft policy.
July 13, 2021
Humana Hears ASNC’s Concerns, Reverses Restrictive PET/CT Coverage Policy
July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the…
Read More
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.
By Dave Fornell, Editor
July 08, 2021
Medtronic Ends Sales of HVAD Ventricular Assist System
Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular…
Read More
The Xeltis synthetic polymer restorative pulmonary valve is implanted surgically and acts as a scaffold for the patient's own cells to proliferate. The valve and conduit then bioresorbs over time, leaving behind a new valve made from the patient's own cells. The hope is this will reduce or eliminate the need for numerous repeat surgeries as a pediatric patient grows.
July 08, 2021
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient
July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve…
Read More
The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.
July 07, 2021
Robocath, Philips and Rennes University Hospital Codevelop Robotic Stroke Intervention System
July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat…
Read More
Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces costs
July 02, 2021
Philips and the Spanish National Center for Cardiovascular Research Collaborate on New Ultra-fast Cardiac MRI Protocol
July 2, 2021 — Philips has participated in an important research project to develop a magnetic resonance (MR) imaging…
Read More
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device
July 01, 2021
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation…
Read More
Abbott says the Xience fluoropolymer coating interacts with blood proteins in a manner that reduces thrombus formation. This feature makes the stent safer to use for shorter duration DAPT.
June 30, 2021
FDA Clears Xience Stent for One Month DAPT in High Risk Bleeding Patients
June 30, 2021 — Abbott announced its Xience family of drug-eluting coronary stents received U.S. Food and Drug…
Read More
Echocardiography Related COVID-19 Research Presented at ASE 2021
June 29, 2021
Echocardiography Related COVID-19 Research Presented at ASE 2021
June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021…
Read More
3 Studies Show How Echocardiography is a Key Tool in Women's Health. Getty Images
June 29, 2021
3 Studies Show How Echocardiography is a Key Tool in Women's Health
June 29, 2021 – Three research studies presented at the American Society of Echocardiography (ASE) 2021 virtual meeting…
Read More
Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.
June 29, 2021
Ultrasound Contrast Agents Greatly Aids in Complex Congenital Heart Imaging
June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now